Clinicopathological and immunohistochemical features of uterine adenomyomatous polyps.
Adenomyomatous polyp
Endometrial polyp
Endometrium
Infertility
Pedunculated adenomyoma
Polypoid adenomyoma
Uterine polyp
Journal
Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
10
08
2018
revised:
27
09
2018
accepted:
04
10
2018
pubmed:
20
10
2018
medline:
16
11
2019
entrez:
20
10
2018
Statut:
ppublish
Résumé
Adenomyomatous polyps (APs) of the uterus (also termed polypoid adenomyomas and pedunculated adenomyomas) are exophytic proliferations composed of myomatous stroma admixed with endometrial glands. APs can be diagnostically challenging, mimicking polypoid neoplasms such as atypical polypoid adenomyoma and adenosarcoma. The purpose of this study was to describe the clinicopathological, morphologic, and molecular features of APs, as well as to raise awareness of this entity as a potential source of diagnostic confusion. We identified APs diagnosed at Brigham and Women's Hospital from 2000 to 2015. We reviewed histologic slides and obtained archival tissue for immunohistochemical and molecular studies. APs seen in consultation were associated with a broad differential, including adenosarcoma, atypical polypoid adenomyoma, and endometrial neoplasia. We performed a histologic review of 84 APs diagnosed at our institution and identified 2 distinct morphologic types of APs, which we have termed type 1 (with vaguely fascicular myomatous stroma intimately admixed with glands) and type 2 (containing a well-defined stalk of smooth muscle entrapping glands). Most APs exhibited CD10-positive (100%; 72/72) and desmin-positive (97%; 70/72) stroma. Diffuse caldesmon positivity was present in 97% (28/29) of type 2 polyps compared with 8% (3/39) of type 1 APs. APs did not harbor mutations in exon 2 of MED12. APs are not uncommon in routine practice and may be misinterpreted as more worrisome lesions. We identified 2 types of APs with distinct morphology and immunophenotype. The absence of MED12 exon 2 mutations suggests that the pathogenesis of APs is separate from uterine leiomyomas.
Identifiants
pubmed: 30339971
pii: S0046-8177(18)30388-5
doi: 10.1016/j.humpath.2018.10.002
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
MED12 protein, human
0
Mediator Complex
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
239-245Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.